U.S. Markets close in 42 mins

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0874-0.0926 (-7.85%)
As of 3:18PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.1800
Open1.2000
Bid1.1700 x 800
Ask1.1800 x 4000
Day's Range1.0800 - 1.2000
52 Week Range1.0200 - 3.8900
Volume1,435,434
Avg. Volume1,004,828
Market Cap95.978M
Beta (5Y Monthly)0.98
PE Ratio (TTM)N/A
EPS (TTM)-0.6990
Earnings DateAug 09, 2021 - Aug 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.25
  • Agile Therapeutics (AGRX) Q2 2021 Earnings Call Transcript
    Motley Fool

    Agile Therapeutics (AGRX) Q2 2021 Earnings Call Transcript

    Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook for the future, management's expectations for our future financial and operational performance, our business strategy, our assessment of the combined hormonal contraceptive market and the potential market share for Twirla, among other statements regarding our plans, prospects, and expectations. Such statements represent our judgments as of today, are not promises or guarantees, and may involve risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking statements.

  • Agile Therapeutics (AGRX) Reports Q2 Loss, Lags Revenue Estimates
    Zacks

    Agile Therapeutics (AGRX) Reports Q2 Loss, Lags Revenue Estimates

    Agile Therapeutics (AGRX) delivered earnings and revenue surprises of 4.76% and -18.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Agile Therapeutics Reports Second Quarter 2021 Financial Results
    GlobeNewswire

    Agile Therapeutics Reports Second Quarter 2021 Financial Results

    Total Prescriptions (TRx) Grew 171% in Second Quarter Prescribers, New Prescriptions and Refill Rates Continue to Grow in Second Quarter Company Continues to Progress on Expanding Access to Twirla Management to Host Conference Call Today, Monday, July 26, 2021 at 4:30 p.m. EDT PRINCETON, N.J., July 26, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended June 30, 2021 and provided a corporate u